Federal appeals court rules to restrict abortion medication
A Federal Appeals court ruled to restrict the abortion medication Mifepristone.
The Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug’s use curtailed.
A Federal Appeals court ruled to restrict the abortion medication Mifepristone.
The court had until end of day Wednesday before Alito’s temporary stay expired.
The announcement comes after an appeals court ruling that would restrict access.
The abortion pill mifepristone is safe enough that retail pharmacies can begin dispensing it so long as a certified health care provider prescribes the drug and if that pharmacy meets certain requirements, according to new rules published Tuesday by the U.S. Food and Drug Administration.